Analysts at Noble Capital Markets have welcomed recent developments at First Phosphate Corp. (CSE:PHOS, OTCQX:FRSPF, FRA:KD0, OTC:FPHOY), which they believe meaningfully reduce technical, funding, and capital markets risk as the company advances toward a feasibility study.
First Phosphate recently received conditional approval for up to C$16.7 million in non-repayable funding through Natural Resources Canada under the Global Partnerships Initiative.
The contribution will fund assessment of technical and engineering parameters, including processing circuits and equipment, needed to validate the company’s ability to produce battery-grade phosphate concentrate aligned with its definitive offtake agreement. Study activities funded by the contribution are expected to continue through 2028.
The company also received about US$523,000 under a long-term phosphate concentrate offtake agreement, providing early cash flow and commercial validation tied to downstream demand.
Further, phosphate was recently added to Canada’s critical minerals list, making First Phosphate eligible for the 30% Critical Mineral Exploration Tax Credit and the 30% Clean Technology Manufacturing Investment Tax Credit.
Additionally, First Phosphate has expanded US investor access by launching a sponsored Level 1 ADR program on the OTCQX under the ticker ‘FPHOY.’ The program allows investors to hold ADRs representing 10 common shares each, broadening US and international access without issuing new shares.
“We view the conditional federal contribution, phosphate’s addition to Canada’s critical minerals list, the launch of the ADR program, and the receipt of the initial offtake pre-payment as clear indicators of accelerating institutional validation,” the analysts wrote.
“In our view, these developments meaningfully reduce technical, funding, and capital markets risk as the company advances toward a feasibility study, supporting continued project de-risking and long-term value creation.”
The analysts have an ‘Outperform’ rating on First Phosphate and US$1.65 price target, which implies significant upside from its share price of US$0.76 at the time of writing. Shares jumped almost 10% to about US$0.84 on Thursday afternoon.